Renalytix (Reg S) (RENX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.62p
   
  • Change Today:
    -0.76p
  • 52 Week High: 12.50p
  • 52 Week Low: 5.62p
  • Currency: UK Pounds
  • Shares Issued: 437.02m
  • Volume: 1,365,133
  • Market Cap: £28.92m
  • RiskGrade: 348

Latest Deals

Traded Action Notifier PriceAmountValue
26-Sep-25 Placing Robert (Rob) Graham Naylor 9.50p 105,263 £9,999.98
26-Sep-25 Placing Catherine Coste 9.50p 105,263 £9,999.98
26-Sep-25 Placing Christopher H B Mills 9.50p 2,500,000 £237,500.00
10-Dec-24 Buy James Renwick McCullough 8.50p 25,000 £2,125.00
05-Dec-24 Buy Christopher H B Mills 7.00p 48,601 £3,402.07

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
26-Sep-25 Placing Christopher H B Mills 9.50p 2,500,000 £237,500.00
26-Sep-25 Placing Catherine Coste 9.50p 105,263 £9,999.98
26-Sep-25 Placing Robert (Rob) Graham Naylor 9.50p 105,263 £9,999.98
05-Dec-24 Buy James Renwick McCullough 7.50p 53,300 £3,997.50
05-Dec-24 Buy Christopher H B Mills 7.00p 48,601 £3,402.07

Director Shareholdings

Notifier Holding Value*
Christopher H B Mills 17,061,345 £1,129,060
James Renwick McCullough 3,242,096 £214,550
Robert (Rob) Graham Naylor 693,318 £45,881
Fergus Fleming 569,481 £37,686
Catherine Coste 385,129 £25,486

Major Shareholders

Notifier** Holding Value*
Heights Capital Management, Inc. 43,151,533 £2,855,616
UBS Group AG 34,949,903 £2,312,861
CVI Holdings, LLC 33,000,000 £2,183,824
Ruffer LLP 28,500,000 £1,886,029
Unicorn Asset Management Limited 25,797,882 £1,707,213
UBS Group AG 22,590,196 £1,494,939
Harwood Capital LLP 17,061,345 £1,129,060
Harwood Capital LLP 14,609,946 £966,835
Polar Capital, LLP 13,196,197 £873,278
Icahn School of Medicine at Mount Sinai 10,750,926 £711,458
Jefferson River Capital LLC 8,294,932 £548,929
Mount Sinai 8,018,986 £530,668
Gilder Gagnon Howe and Co LLC 6,042,634 £399,880
Forest Nominees Limited 4,001,187 £264,784
Lombard Odier & Co Ltd 2,952,334 £195,375
Amati Global Investors 2,455,247 £162,480
Fidelity Investment International 2,173,851 £143,858

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 6.62p
Change Today -0.76p
% Change -10.33 %
52 Week High 12.50p
52 Week Low 5.62p
Volume 1,365,133
Shares Issued 437.02m
Market Cap £28.92m
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

RENX Dividends

No dividends found

Trades for 04-Nov-2025

Time Volume / Share Price
11:05 182 @ 6.80p
11:02 9,009 @ 6.81p
11:01 50,000 @ 6.81p
11:00 13,500 @ 7.00p
11:00 500 @ 7.00p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page